Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast CancerAyca Gucalp, Tiffany A. Traina, Minetta C. Liu et al.|Clinical Cancer Research|2013Cited by 744
Targeting the androgen receptor (AR) in women with AR+ ER-/PR- metastatic breast cancer (MBC).Ayca Gucalp, Tiffany A. Traina, Sara M. Tolaney et al.|Journal of Clinical Oncology|2012Cited by 31